clinical trial · NCT07392736
A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Advenchen Laboratories, LLC·phase2·recruiting·n = 228
Solid TumorAL8326 tabletsToripalimab
brief summary
This trial is an open, non-randomized, phase I/IIa clinical trial, which will evaluate the preliminary effectiveness and safety of AL8326 tablets in patients with advanced solid tumors
started
Oct 26, 2021
primary completion
Nov 7, 2029
completion
Nov 7, 2029
last updated
Feb 6, 2026
official title
A Phase I/IIa Clinical Trial of AL8326 Tablets Combined With Toripalimab in the Treatment of Advanced Recurrent or Metastatic Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol